Cargando…
PD-1 Blockade and OX40 Triggering Synergistically Protects against Tumor Growth in a Murine Model of Ovarian Cancer
The co-inhibitory receptor Programmed Death-1 (PD-1) curtails immune responses and prevent autoimmunity, however, tumors exploit this pathway to escape from immune destruction. The co-stimulatory receptor OX40 is upregulated on T cells following activation and increases their clonal expansion, survi...
Autores principales: | Guo, Zhiqiang, Wang, Xin, Cheng, Dali, Xia, Zhijun, Luan, Meng, Zhang, Shulan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3937343/ https://www.ncbi.nlm.nih.gov/pubmed/24586709 http://dx.doi.org/10.1371/journal.pone.0089350 |
Ejemplares similares
-
Correction: PD-1 Blockade and OX40 Triggering Synergistically Protects against Tumor Growth in a Murine Model of Ovarian Cancer
por: Guo, Zhiqiang, et al.
Publicado: (2017) -
Combined TIM-3 blockade and CD137 activation affords the long-term protection in a murine model of ovarian cancer
por: Guo, Zhiqiang, et al.
Publicado: (2013) -
Combined Trabectedin and anti-PD1 antibody produces a synergistic antitumor effect in a murine model of ovarian cancer
por: Guo, Zhiqiang, et al.
Publicado: (2015) -
Crucial role of OX40/OX40L signaling in a murine model of asthma
por: Lei, Wei, et al.
Publicado: (2018) -
OX40 agonism enhances PD-L1 checkpoint blockade by shifting the cytotoxic T cell differentiation spectrum
por: van der Sluis, Tetje C., et al.
Publicado: (2023)